AIP
BPTH

Ameritas Investment Partners’s Bio-Path Holdings Inc BPTH Stock Holding History

Ameritas Investment Partners’s Portfolio BPTH Stock Details BPTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2
Closed -$5K – 3064
2017
Q1 		$5K Buy
+2
New +$7.26K ﹤0.01% 2850

Other funds holding BPTH

UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $863M AUM 30.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RCA
Rowland Carmichael Advisors Scottsdale, Arizona $316M AUM 18.07% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Ameritas Investment Partners's BPTH Position: Q2 2017 in Review

Ameritas Investment Partners sold out of Bio-Path Holdings Inc (BPTH) in Q2 2017, closing a stake of 2 shares — an estimated $5K sold.

Ameritas Investment Partners first reported a position in BPTH in Q1 2017 and held it in 1 quarter. The position peaked at $5K in Q1 2017. 33 funds tracked by Wall St. Rank hold BPTH as of Q2 2017.

  • Ameritas Investment Partners reported no remaining Bio-Path Holdings Inc position as of Q2 2017 after selling out during the quarter.
  • Ameritas Investment Partners sold 2 Bio-Path Holdings Inc shares in Q2 2017, an estimated $5K.
  • Ameritas Investment Partners first reported a position in Bio-Path Holdings Inc in Q1 2017 and held it in 1 quarter.
  • Ameritas Investment Partners's Bio-Path Holdings Inc position peaked at $5K in Q1 2017.
  • 33 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q2 2017.

Based on Ameritas Investment Partners's 13F filing for Q2 2017, filed 15 Aug 2017.